Luly Jay R.

Executive buyer

Director, President and CEO · ENANTA PHARMACEUTICALS INC

Every open-market stock purchase Luly Jay R. has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. This page tracks where how the prices paid compare to where the stock trades now.

Total bought

$256.1K

Open-market buys

Companies

Last buy

Feb 12, 2025

Where the buys stand today

ENTA
ENANTA PHARMACEUTICALS INC
One purchase totalling $256.1K at an average of $5.69 per share. See all insider buying in ENTA →
Avg price paid
$5.69
Latest price
—
Market cap
Unknown

All reported buys

Date	Ticker	Shares	Price	Value	Filing
Feb 12, 2025	ENTA	45,000	$5.69	$256.1K	SEC ↗

Follow new qualifying clusters involving Luly Jay R. or other insiders

Explore qualifying clusters from public SEC filings. Pro adds email and Telegram notifications after detection.

Start a trial See pricing

About this data

Figures are parsed from Luly Jay R.'s Form 4 filings on SEC EDGAR (CIK 1571211) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.

This page is informational and reflects public filing data. It is not investment advice.